Lin Long

675 total citations
34 papers, 281 citations indexed

About

Lin Long is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lin Long has authored 34 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lin Long's work include Esophageal Cancer Research and Treatment (5 papers), RNA modifications and cancer (5 papers) and Gut microbiota and health (4 papers). Lin Long is often cited by papers focused on Esophageal Cancer Research and Treatment (5 papers), RNA modifications and cancer (5 papers) and Gut microbiota and health (4 papers). Lin Long collaborates with scholars based in China, Canada and United States. Lin Long's co-authors include En‐Min Li, Li‐Yan Xu, Lian‐Di Liao, Xiu‐E Xu, Jian‐Yi Wu, Jianzhong He, Feng Pan, Hongjun Luo, D F Mutasim and Xiaoxiao Pang and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Chemical Engineering Journal.

In The Last Decade

Lin Long

26 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Long China 10 165 75 42 33 30 34 281
Veronika Borutinskaitė Lithuania 11 226 1.4× 35 0.5× 64 1.5× 28 0.8× 18 0.6× 31 391
Xuewu Sun China 12 293 1.8× 105 1.4× 39 0.9× 84 2.5× 58 1.9× 19 452
Frédéric Paré Canada 11 177 1.1× 33 0.4× 38 0.9× 73 2.2× 54 1.8× 23 355
Venus Onay United States 9 213 1.3× 46 0.6× 21 0.5× 84 2.5× 18 0.6× 15 379
Xuemei Du China 11 154 0.9× 32 0.4× 44 1.0× 55 1.7× 24 0.8× 48 352
Takahiro Kimura Japan 9 248 1.5× 54 0.7× 37 0.9× 95 2.9× 16 0.5× 37 489
Lingling Peng China 13 174 1.1× 52 0.7× 17 0.4× 19 0.6× 34 1.1× 27 316
Zhe Yang China 10 123 0.7× 71 0.9× 73 1.7× 34 1.0× 7 0.2× 34 297
Huangheng Tao China 11 193 1.2× 47 0.6× 16 0.4× 26 0.8× 17 0.6× 14 276

Countries citing papers authored by Lin Long

Since Specialization
Citations

This map shows the geographic impact of Lin Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Long more than expected).

Fields of papers citing papers by Lin Long

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Long. The network helps show where Lin Long may publish in the future.

Co-authorship network of co-authors of Lin Long

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Long. A scholar is included among the top collaborators of Lin Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Long. Lin Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Xintao, Tao Jiang, Xiaochen Wu, et al.. (2025). The fucoidan delivery system enhanced the anti-cervical cancer effect of caffeic acid. International Journal of Biological Macromolecules. 307(Pt 3). 141976–141976. 3 indexed citations
2.
Zeng, Wenjing, Juan Gu, Ying He, et al.. (2025). Hyperoxia as a driver of gut dysbiosis. Frontiers in Microbiology. 16. 1675652–1675652.
3.
Wu, Xinyi, et al.. (2025). Exploring solute carriers as biomarkers and therapeutic targets in esophageal squamous cell carcinoma. International Journal of Cancer. 158(1). 19–32.
4.
Long, Lin, Xiaojing Yuan, Lili Ma, et al.. (2025). Transcutaneous electrotherapy of facial nerve injuries based on dissolvable conductive microneedles. Bioactive Materials. 53. 630–640.
5.
Yu, Zhe, et al.. (2025). Dual-targeted fucoidan-TPP nanoparticles delivery system potently inhibit breast cancer via mitochondrial dysfunction and cGAS-STING activation. Colloids and Surfaces B Biointerfaces. 258. 115279–115279. 1 indexed citations
6.
Long, Lin, et al.. (2025). An AFS/DYC cooperative control method based on model prediction and phase plane stability analysis. Proceedings of the Institution of Mechanical Engineers Part D Journal of Automobile Engineering.
7.
Wang, Yinghan, et al.. (2025). Improved bioavailability and anti-nephrotoxicity efficacy of polydatin on cisplatin-induced AKI via a dual-targeting fucoidan delivery system. International Journal of Pharmaceutics X. 10. 100422–100422.
8.
Long, Lin, et al.. (2024). Implications of intestinal microecology and immune function alterations for immunotherapy outcomes in advanced unresectable lung adenocarcinoma. The Clinical Respiratory Journal. 18(5). e13762–e13762. 2 indexed citations
9.
Shi, Zhiqi, et al.. (2024). Revolutionizing NSCLC Treatment: Immunotherapy Strategies for EGFR‐TKIs Resistance. The Clinical Respiratory Journal. 18(12). e70037–e70037.
10.
Long, Lin, Chengyu Li, Yingxin Zhou, et al.. (2024). Splicing factor hnRNPA1 regulates alternative splicing of LOXL2 to enhance the production of LOXL2Δ13. Journal of Biological Chemistry. 300(7). 107414–107414. 5 indexed citations
11.
Li, Yongkang, et al.. (2023). Friend or Foe: Regulation, Downstream Effectors of RRAD in Cancer. Biomolecules. 13(3). 477–477. 7 indexed citations
12.
Xu, Li‐Yan, et al.. (2022). TRIP13 Induces Nedaplatin Resistance in Esophageal Squamous Cell Carcinoma by Enhancing Repair of DNA Damage and Inhibiting Apoptosis. BioMed Research International. 2022(1). 7295458–7295458. 9 indexed citations
13.
Zhang, Zhi‐Da, Bing Wen, Xiaodong Wu, et al.. (2022). AKT serine/threonine kinase 2-mediated phosphorylation of fascin threonine 403 regulates esophageal cancer progression. The International Journal of Biochemistry & Cell Biology. 145. 106188–106188. 9 indexed citations
14.
Huang, Guowei, Chunquan Li, Lian‐Di Liao, et al.. (2019). LncRNA625 inhibits STAT1-mediated transactivation potential in esophageal cancer cells. The International Journal of Biochemistry & Cell Biology. 117. 105626–105626. 9 indexed citations
15.
Long, Lin, Jianzhong He, Ye Chen, et al.. (2018). Riboflavin Depletion Promotes Tumorigenesis in HEK293T and NIH3T3 Cells by Sustaining Cell Proliferation and Regulating Cell Cycle–Related Gene Transcription. Journal of Nutrition. 148(6). 834–843. 18 indexed citations
16.
Long, Lin, Xiaoxiao Pang, Fei Lei, et al.. (2018). SLC52A3 expression is activated by NF-κB p65/Rel-B and serves as a prognostic biomarker in esophageal cancer. Cellular and Molecular Life Sciences. 75(14). 2643–2661. 42 indexed citations
17.
18.
Zhang, Xiaodan, Jian‐Jun Xie, Lian‐Di Liao, et al.. (2015). 12-O-Tetradecanoylphorbol-13-Acetate Induces Up-Regulated Transcription of Variant 1 but Not Variant 2 of VIL2 in Esophageal Squamous Cell Carcinoma Cells via ERK1/2/AP-1/Sp1 Signaling. PLoS ONE. 10(4). e0124680–e0124680. 7 indexed citations
19.
Zhang, Haifeng, Kai Zhang, Lian‐Di Liao, et al.. (2013). miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2. Carcinogenesis. 35(2). 292–301. 47 indexed citations
20.
Yang, Fan, Yuping Xu, Jian Li, et al.. (2009). Cloning and characterization of a novel intracellular protein p48.2 that negatively regulates cell cycle progression. The International Journal of Biochemistry & Cell Biology. 41(11). 2240–2250. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Veronika Borutinskaitė Breakdown of academic impact, for papers by Xuewu Sun Breakdown of academic impact, for papers by Frédéric Paré Breakdown of academic impact, for papers by Venus Onay Breakdown of academic impact, for papers by Xuemei Du Breakdown of academic impact, for papers by Takahiro Kimura Breakdown of academic impact, for papers by Lingling Peng Breakdown of academic impact, for papers by Zhe Yang Breakdown of academic impact, for papers by Huangheng Tao
Rankless by CCL
2026